HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical evaluation of Claforan (CTX) in aged patients with chronic complicated urinary tract infections].

Abstract
Claforan (CTX) was administered for 5 days at a daily dose of 4 g in two divided doses by intravenous injection to 18 in-patients, all of whom were over 70 years old and had chronic complicated urinary tract infections. The overall clinical efficacy of CTX was excellent in 4 cases, moderate in 8 cases and poor in 6 cases, the overall effectiveness rate being 66.7%. Twenty seven out of 34 organisms isolated from chronic complicated urinary tract infections before administration of CTX were eradicated after treatment. Both clinical findings and laboratory findings revealed no side effects. It is suggested that CTX is useful and a safe drug for elderly patients.
AuthorsH Washida, M Tsugaya, N Hirao, Y Hachisuka
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 30 Issue 1 Pg. 121-9 (Jan 1984) ISSN: 0018-1994 [Print] Japan
PMID6328960 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Cefotaxime
Topics
  • Aged
  • Cefotaxime (administration & dosage, therapeutic use)
  • Drug Evaluation
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Urinary Tract Infections (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: